Bristol-Myers Squibb Renews License for Ingenuity Systems Software

Sep 02, 2008

NEW YORK (GenomeWeb News) – Bristol-Myers Squibb has renewed its license for Ingenuity Systems’ pathway analysis software for use in genomics and proteomics research aimed at advancing its drug discovery programs, Ingenuity said today.

Under the agreement, Bristol-Myers Squibb gains enterprise-wide access to the Ingenuity Pathways Analysis software for modeling, visualization, and interpretation of genomics and proteomics data. BMS has been an Ingenuity customer since 2004.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

New Privacy Coalition

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

Less Sweat, More Diverse Microbiome

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

Oh, This Code

The Wall Street Journal examines billing codes used by uBiome.

PNAS Studies Look at Lung Cancer LncRNA, Hi-C Clustering, and More

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.

Menu